Researchers: lowering fever slows recovery and may promote viral spread

Editorial note: This article was previously published and updated according to scientific and divulgative criteria. The purpose is to inform: it does not replace medical advice nor does it provide personalized clinical recommendations.

In brief

• Fever is a physiological mechanism that alters immune and biochemical functions and can promote the response to infection.
• In animal models and some observational studies, the systematic use of antipyretics has been associated with worse outcomes; human data are limited and contextual.
• Mathematical analyses suggest that widespread fever suppression can increase large-scale transmission, but estimates depend on model assumptions.
• In controlled clinical trials on adult influenza, paracetamol did not show clear benefits on duration or viral load; evidence is heterogeneous.
• Decisions on fever treatment must consider clinical context, individual vulnerability, and objectives (comfort vs. spread control).

Abstract: what does science say?

Fever is the temporary elevation of body temperature regulated by the central nervous system in response to inflammatory signals. In vitro experiments and experimental studies agree that temperatures in the febrile range influence key immune functions — increased activity of innate cells (e.g., neutrophils, NK), improved antibody affinity in controlled experiments, and modulation of adaptive responses. On the other hand, animal models and systematic reviews show that pharmacological suppression of fever can increase mortality in some experimental models, while a published mathematical model estimated a possible impact on transmission in seasonal populations. In humans, controlled clinical evidence is limited and does not provide a clear picture: a randomized trial on influenza found no clear differences with paracetamol, and studies on experimental colds showed tendencies towards prolonged viral shedding in some cases. In summary, the biological plausibility that fever contributes to defense is solid, experimental evidence in models supports relevant effects, while clinical evidence in human populations remains partial and contextualized. Methodological limitations (generalizability from animal models, trial size, variability of pathogens and contexts) necessitate a cautious and non-causal interpretation: practical indications must weigh comfort, individual risk, and the collective impact of symptom management.

What it means in practice

For non-healthcare professionals, the practical message is one of balance and awareness. Fever is not always an enemy: it is a response that modifies the biological environment and the activity of immune cells. In many healthy people, a moderate fever accompanies a self-limiting course and contributes to immune activation. However, fever management can depend on the objective: improving comfort and allowing rest, or influencing the duration and transmissibility of the infection at a collective level. Experimental studies and models suggest that widespread fever suppression could, in theory, prolong the duration of contagiousness and favor large-scale spread; but clinical evidence in people is heterogeneous and does not confirm large effects in all contexts [1][2][3].

In practice, this means that: - antipyretic treatment remains useful for those with significant discomfort, pain, or conditions that make fever dangerous; - in low-risk individuals (healthy adults with low-to-moderate fever), rest, hydration, and monitoring can be reasonable strategies; - for fragile individuals (very young children, the elderly, people with chronic diseases or immunosuppression), management should be evaluated with a doctor.

Why fever can be useful (biological mechanisms)

Effects on innate and adaptive cells

Temperatures in the febrile range (generally 1–4 °C above basal temperature) alter the function of innate and adaptive immune cells. Review research synthesizes evidence that febrile heat increases the recruitment and activity of neutrophils, enhances the cytotoxicity of natural killer cells, and promotes the activation of T lymphocytes in lymph nodes through mechanisms related to thermolabile cytokines and changes in lymphocyte adhesion and trafficking dynamics [5].

Antibody affinity and molecular interactions

In vitro experiments show that for some antigens, the affinity of monoclonal antibodies can increase at temperatures around 40 °C compared to physiological temperature, suggesting that fever could improve the capture and neutralization of some pathogens under particular conditions [6]. These results are not automatically generalizable but support a biological plausibility for the adaptive function of fever.

Experimental evidence, animal models, and mathematical models

Animal models and risks

A systematic review and meta-analysis of animal models of influenza reported an increase in mortality in subjects treated with antipyretics compared to controls, with a pooled odds ratio of around 1.34 in those experimental models [3]. Such results indicate a potential risk associated with fever suppression in some experimental contexts, but generalizability to humans is limited by species differences, viral strains used, and experimental conditions.

Population models

Published mathematical analyses have estimated the impact on seasonal transmission resulting from widespread fever suppression: the work published in Proceedings of the Royal Society proposed that, given certain behavioral and contact assumptions, reducing fever in the population could increase virus spread at an epidemiological level [1]. These estimates depend heavily on model assumptions (contact rate, percentage of people taking antipyretics, effect of fever on contagiousness duration) and should therefore be interpreted as theoretical indications and not as definitive causal evidence.

Clinical evidence in humans

In experimental studies in humans, results are variable. A randomized, controlled, and blinded trial in adults with influenza showed that regular administration of paracetamol at maximum dose for five days did not significantly alter viral load, mean temperature, or overall symptom duration in that specific sample [2]. Experimental studies on volunteers exposed to rhinovirus, however, showed tendencies towards prolonged viral shedding with aspirin and paracetamol in some arms, without producing unequivocal results on clinical severity [4].

Thus, while models and experimental data suggest potential adverse effects of fever suppression, available clinical trials do not provide clear confirmation of similar large-scale effects in the human population: the quality, size, and design of studies necessitate a cautious approach in translating them into practical recommendations.

Specific risks and vulnerable contexts

In hospital settings and in critically ill patients, the use of antipyretics has been associated with different outcomes depending on the context: a multicenter observational study in critically ill patients reported that, in patients with sepsis, the administration of NSAIDs or acetaminophen was associated with an increase in 28-day mortality, while in non-septic patients the picture was different [8]. This type of study does not prove causality but indicates the need to evaluate on a case-by-case basis and not to extend general rules without considering the clinical situation.

Key points to remember

• Fever is an immune response with biological plausibility in favor of defense; various cellular mechanisms are influenced by heat [5][6][7].
• Models and animal studies indicate that fever suppression can worsen some experimental outcomes, but translation to humans is uncertain [3].
• A mathematical model estimated a possible population impact of fever suppression on seasonal transmission, but estimates depend on model assumptions [1].
• Human clinical trials are limited and do not show clear consistent effects of paracetamol on infection duration in the adult population studied [2][4].
• For fragile individuals or in hospital settings, management must be personalized and guided by a doctor; observational studies suggest caution in septic patients [8].

Limitations of evidence

It is important to distinguish between types of evidence: mathematical models and experimental studies provide biological plausibility and hypotheses, while only large, randomized clinical trials and population studies can evaluate causal effects in humans. The main limitations here are:

• Generalizability: many positive studies come from animal models or controlled experiments that do not fully reproduce human complexity.
• Size and power: human trials are often small or not designed to evaluate population outcomes or mortality.
• Pathogen heterogeneity: effects vary depending on the virus (influenza, rhinovirus, others) and its temperature sensitivity.
• Confounding: in observational studies, the use of antipyretics may be correlated with initial disease severity, healthcare behavior, and access to care.

Editorial conclusion

Scientific evidence indicates that fever plays relevant biological roles in the immune response and that its pharmacological suppression is not a biologically neutral intervention. However, the translation from experimental models and mathematical models to clinical and public health practice requires caution: available human clinical evidence is not sufficient to support general rules prohibiting or mandating the use of antipyretics in the community. The decision to treat fever should therefore balance the need for comfort, the severity of the clinical picture, individual vulnerability, and the possible consequence on spread in epidemic situations. Broader and well-designed clinical research is needed to clarify the magnitude and contexts of the effect.

Editorial note

The text is updated with published scientific evidence and verifiable references. It does not replace medical advice: for personal decisions, contact your primary care physician or local health service.

Scientific research

1. Earn DJ, Andrews PW, Bolker BM. Population-level effects of suppressing fever. Proc Biol Sci. 2014;281(1778):20132570. https://doi.org/10.1098/rspb.2013.2570
2. Jefferies S et al. Randomized controlled trial of the effect of regular paracetamol on influenza infection. Respirology. 2016. https://doi.org/10.1111/resp.12685
3. Beasley R, et al. The effect on mortality of antipyretics in the treatment of influenza infection: systematic review and meta-analysis. J R Soc Med. 2010. https://doi.org/10.1258/jrsm.2010.090441
4. Graham NMH, Burrell CJ, Douglas RM, et al. Adverse effects of aspirin, acetaminophen, and ibuprofen on immune function, viral shedding, and clinical status in rhinovirus-infected volunteers. J Infect Dis. 1990;162(6):1277-1282. https://doi.org/10.1093/infdis/162.6.1277
5. Evans SS, Repasky EA, Fisher DT. Fever and the thermal regulation of immunity: the immune system feels the heat. Nat Rev Immunol. 2015;15:335–349. https://doi.org/10.1038/nri3843
6. Stan RC, Françoso KS, Alves RPS, et al. Febrile temperatures increase in vitro antibody affinity for malarial and dengue antigens. PLoS Negl Trop Dis. 2019;13(4):e0007239. https://doi.org/10.1371/journal.pntd.0007239
7. Keitelman IA, Sabbione F, Shiromizu CM, et al. Short-term fever-range hyperthermia accelerates NETosis and reduces pro-inflammatory cytokine secretion by human neutrophils. Front Immunol. 2019;10:2374. https://doi.org/10.3389/fimmu.2019.02374
8. Fever and Antipyretic in Critically ill patients Evaluation (FACE) Study Group. Association of body temperature and antipyretic treatments with mortality of critically ill patients with and without sepsis: multi-centered prospective observational study. Crit Care. 2012;16:R33. https://doi.org/10.1186/cc11211